ELEVANCE HEALTH INC (A58.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:A58 - US0367521038 - Common Stock
317 EUR
+8.7 (+2.82%)
We assign a fundamental rating of 3 out of 10 to A58. A58 was compared to 29 industry peers in the Health Care Providers & Services industry. While A58 is still in line with the averages on profitability rating, there are concerns on its financial health. While showing a medium growth rate, A58 is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year A58 was profitable.
A58 had a positive operating cash flow in the past year.
In the past 5 years A58 has always been profitable.
In the past 5 years A58 always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of A58 (4.51%) is better than 79.31% of its industry peers.
Looking at the Return On Equity, with a value of 12.59%, A58 is in the better half of the industry, outperforming 68.97% of the companies in the same industry.
A58 has a Return On Invested Capital (5.60%) which is in line with its industry peers.
A58 had an Average Return On Invested Capital over the past 3 years of 6.90%. This is in line with the industry average of 6.33%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.51% | ||
| ROE | 12.59% | ||
| ROIC | 5.6% |
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
1.3 Margins
A58 has a Profit Margin (2.84%) which is in line with its industry peers.
A58's Profit Margin has declined in the last couple of years.
A58's Operating Margin of 4.35% is in line compared to the rest of the industry. A58 outperforms 44.83% of its industry peers.
In the last couple of years the Operating Margin of A58 has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.35% | ||
| PM (TTM) | 2.84% | ||
| GM | N/A |
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so A58 is destroying value.
A58 has less shares outstanding than it did 1 year ago.
The number of shares outstanding for A58 has been reduced compared to 5 years ago.
The debt/assets ratio for A58 is higher compared to a year ago.
2.2 Solvency
The Debt to FCF ratio of A58 is 8.63, which is on the high side as it means it would take A58, 8.63 years of fcf income to pay off all of its debts.
A58's Debt to FCF ratio of 8.63 is in line compared to the rest of the industry. A58 outperforms 55.17% of its industry peers.
A58 has a Debt/Equity ratio of 0.71. This is a neutral value indicating A58 is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.71, A58 is in the better half of the industry, outperforming 75.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 8.63 | ||
| Altman-Z | N/A |
ROIC/WACC0.67
WACC8.41%
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
3. Growth
3.1 Past
A58 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.71%.
The Earnings Per Share has been growing by 11.17% on average over the past years. This is quite good.
A58 shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.96%.
Measured over the past years, A58 shows a quite strong growth in Revenue. The Revenue has been growing by 11.14% on average per year.
EPS 1Y (TTM)-11.71%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-27.96%
Revenue 1Y (TTM)11.96%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%10.95%
3.2 Future
A58 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.78% yearly.
Based on estimates for the next years, A58 will show a small growth in Revenue. The Revenue will grow by 4.62% on average per year.
EPS Next Y-8.14%
EPS Next 2Y-8.99%
EPS Next 3Y-1.44%
EPS Next 5Y7.78%
Revenue Next Year13.06%
Revenue Next 2Y8.17%
Revenue Next 3Y6.96%
Revenue Next 5Y4.62%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 12.14 indicates a correct valuation of A58.
Compared to the rest of the industry, the Price/Earnings ratio of A58 indicates a somewhat cheap valuation: A58 is cheaper than 79.31% of the companies listed in the same industry.
A58's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.17.
The Price/Forward Earnings ratio is 13.64, which indicates a correct valuation of A58.
Compared to the rest of the industry, the Price/Forward Earnings ratio of A58 indicates a somewhat cheap valuation: A58 is cheaper than 68.97% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.79, A58 is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.14 | ||
| Fwd PE | 13.64 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of A58 indicates a slightly more expensive valuation: A58 is more expensive than 62.07% of the companies listed in the same industry.
A58's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. A58 is more expensive than 65.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.25 | ||
| EV/EBITDA | 10.58 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)1.09
EPS Next 2Y-8.99%
EPS Next 3Y-1.44%
5. Dividend
5.1 Amount
A58 has a Yearly Dividend Yield of 1.95%.
A58's Dividend Yield is a higher than the industry average which is at 1.45.
Compared to an average S&P500 Dividend Yield of 1.94, A58 has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.95% |
5.2 History
The dividend of A58 is nicely growing with an annual growth rate of 15.34%!
Dividend Growth(5Y)15.34%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
27.56% of the earnings are spent on dividend by A58. This is a low number and sustainable payout ratio.
The dividend of A58 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP27.56%
EPS Next 2Y-8.99%
EPS Next 3Y-1.44%
FRA:A58 (1/6/2026, 7:00:00 PM)
317
+8.7 (+2.82%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners91.68%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap70.45B
Revenue(TTM)194.82B
Net Income(TTM)5.53B
Analysts74.29
Price Target339.49 (7.09%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.95% |
Yearly Dividend5.57
Dividend Growth(5Y)15.34%
DP27.56%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.38%
Min EPS beat(2)-2.26%
Max EPS beat(2)21.02%
EPS beat(4)3
Avg EPS beat(4)5.76%
Min EPS beat(4)-2.26%
Max EPS beat(4)21.02%
EPS beat(8)5
Avg EPS beat(8)0.95%
EPS beat(12)8
Avg EPS beat(12)1.31%
EPS beat(16)11
Avg EPS beat(16)1.68%
Revenue beat(2)2
Avg Revenue beat(2)0.95%
Min Revenue beat(2)0.45%
Max Revenue beat(2)1.45%
Revenue beat(4)4
Avg Revenue beat(4)1.62%
Min Revenue beat(4)0.29%
Max Revenue beat(4)4.3%
Revenue beat(8)7
Avg Revenue beat(8)1.16%
Revenue beat(12)9
Avg Revenue beat(12)1.25%
Revenue beat(16)12
Avg Revenue beat(16)1.04%
PT rev (1m)1.09%
PT rev (3m)-39.06%
EPS NQ rev (1m)-1.44%
EPS NQ rev (3m)-23.7%
EPS NY rev (1m)0%
EPS NY rev (3m)0.31%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)0.32%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)0.65%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.14 | ||
| Fwd PE | 13.64 | ||
| P/S | 0.42 | ||
| P/FCF | 22.25 | ||
| P/OCF | 17.01 | ||
| P/B | 1.88 | ||
| P/tB | 19.83 | ||
| EV/EBITDA | 10.58 |
EPS(TTM)26.11
EY8.24%
EPS(NY)23.24
Fwd EY7.33%
FCF(TTM)14.25
FCFY4.5%
OCF(TTM)18.63
OCFY5.88%
SpS746.06
BVpS168.32
TBVpS15.99
PEG (NY)N/A
PEG (5Y)1.09
Graham Number314.46
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.51% | ||
| ROE | 12.59% | ||
| ROCE | 7.32% | ||
| ROIC | 5.6% | ||
| ROICexc | 6.06% | ||
| ROICexgc | 10.93% | ||
| OM | 4.35% | ||
| PM (TTM) | 2.84% | ||
| GM | N/A | ||
| FCFM | 1.91% |
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
ROICexc(3y)7.45%
ROICexc(5y)7.72%
ROICexgc(3y)13.9%
ROICexgc(5y)14.63%
ROCE(3y)9.03%
ROCE(5y)9.4%
ROICexgc growth 3Y-5.49%
ROICexgc growth 5Y-3.16%
ROICexc growth 3Y-5.02%
ROICexc growth 5Y-2.23%
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 8.63 | ||
| Debt/EBITDA | 3.13 | ||
| Cap/Depr | 74.45% | ||
| Cap/Sales | 0.59% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 48.59% | ||
| Profit Quality | 67.25% | ||
| Current Ratio | N/A | ||
| Quick Ratio | N/A | ||
| Altman-Z | N/A |
F-Score4
WACC8.41%
ROIC/WACC0.67
Cap/Depr(3y)77.74%
Cap/Depr(5y)81.03%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.76%
Profit Quality(3y)103.66%
Profit Quality(5y)128.32%
High Growth Momentum
Growth
EPS 1Y (TTM)-11.71%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-27.96%
EPS Next Y-8.14%
EPS Next 2Y-8.99%
EPS Next 3Y-1.44%
EPS Next 5Y7.78%
Revenue 1Y (TTM)11.96%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%10.95%
Revenue Next Year13.06%
Revenue Next 2Y8.17%
Revenue Next 3Y6.96%
Revenue Next 5Y4.62%
EBIT growth 1Y-10.69%
EBIT growth 3Y0%
EBIT growth 5Y6.19%
EBIT Next Year-2.04%
EBIT Next 3Y0.56%
EBIT Next 5Y8.31%
FCF growth 1Y-54.88%
FCF growth 3Y-14.89%
FCF growth 5Y-2.08%
OCF growth 1Y-48.85%
OCF growth 3Y-11.78%
OCF growth 5Y-1.08%
ELEVANCE HEALTH INC / A58.DE FAQ
Can you provide the ChartMill fundamental rating for ELEVANCE HEALTH INC?
ChartMill assigns a fundamental rating of 3 / 10 to A58.DE.
What is the valuation status of ELEVANCE HEALTH INC (A58.DE) stock?
ChartMill assigns a valuation rating of 3 / 10 to ELEVANCE HEALTH INC (A58.DE). This can be considered as Overvalued.
What is the profitability of A58 stock?
ELEVANCE HEALTH INC (A58.DE) has a profitability rating of 4 / 10.
Can you provide the expected EPS growth for A58 stock?
The Earnings per Share (EPS) of ELEVANCE HEALTH INC (A58.DE) is expected to decline by -8.14% in the next year.
Is the dividend of ELEVANCE HEALTH INC sustainable?
The dividend rating of ELEVANCE HEALTH INC (A58.DE) is 5 / 10 and the dividend payout ratio is 27.56%.